Ardent Health Partners, LLC (NYSE: ARDT) had its price target raised by analysts at Leerink Partners from $23.00 to $25.00. They now have an "outperform" rating on the stock.
Ardent Health Reports Third Quarter 2024 Results
Ardent Health Partners, LLC (NYSE: ARDT) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $19.00 price target on the stock, down previously from $22.00.
Ardent Health to Participate in Upcoming Investor Conferences
Ardent Health Announces Third Quarter 2024 Results Conference Call and Webcast Date